Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/3c59053a-e29e-4bc5-9e1e-64cb490bd2e4/
VRDN
Viridian Therapeutics IncSnapshot 2026-06-07 · 0.0w · Fresh
Strategy Eligibility
1 of 23 passing
★
OS Composite
✗
↗
Trending Value
✗
◆
Quality × Value
✗
🏛
Cornerstone Value
✗
🌿
Cornerstone Growth
✗
💎
Deep Value
✗
◇
VC2 Cheapest
✗
📐
EBITDA/EV
✗
◐
Veiled Value
✗
▣
Piotroski Bargains
✗
🔬
Quality Compounders
✗
📈
Consistent Earners
Noneyr
🌱
GARP
✗
🔄
Shareholder Yield
✗
💰
High Yield
✗
🚀
Momentum Leaders
✗
◉
Market Leaders
✗
◎
Tiny Titans
✗
🔍
Small Cap Value
✗
🛡
Low Volatility
✗
🏷
Sector Cheapest
✗
🧠
Capital Allocators
✗
⚡
Risk-Adj Momentum
✗
V
Value Analysis
Cheapness relative to fundamentals
35.0%ile
P/S
22.7×
P/B
2.5×
FCF Yield
-0.204
SH Yield
0.000
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
65.00000000
/100 — 1=cheapest
VC2 (Trending Value)
65.00000000
/100
VC3 (Buyback)
65.00000000
/100
Negative FCF yield (-20.4%) — the business is currently cash-consumptive.
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
35.0%ile
ROE
-0.567
ROA
-0.457
Net Margin
-5.085
Op Margin
-5.137
GPA
0.089
D/E
0.24
Current
15.15
F-Score
2/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Stability
0.317
lower=better
Accruals
-0.072
lower=better
5yr Consist
Yes
Conservative balance sheet with D/E of 0.24. F-Score of 2/9 flags fundamental deterioration — multiple signals are weakening.
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
35.0%ile
6M Return
-50.7%
12M Return
7.5%
12-1 Mom
13.1%
Risk-Adj
0.21
Vol 252d
62.2%
Vol 60d
148.3%
↑ Expanding
Max DD 12M
-59.7%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
Near-term vol (148%) is expanding vs long-term (62%) — risk is increasing.
OS
Composite & Factor Heatmap
All factors at a glance
0.2
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
▦
Sector Context
Healthcare
· 500 peers
Sector Value %ile
10.0%
Sector Quality %ile
10.2%
P/B z-score
-0.21
Sector Avg OS
63.3%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
Factor Interactions
Volatility Expanding
60-day vol (148%) significantly exceeds 252-day (62%). Near-term risk is elevated.
⚖
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
F
21.0% avg (4 factors)
Quality
D
37.6% avg (8 factors)
Momentum
D
30.7% avg (4 factors)
Risk
F
13.0% avg (1 factors)
Momentum is weak, suggesting the market isn't yet buying this thesis. Patience required. Elevated risk profile — position sizing should reflect the higher volatility.
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Factor Persistence1 snapshots
| Factor | Current | Streak | Trend | Spark |
|---|---|---|---|---|
| OS Composite | 0.200 | —1 | — | |
| Value %ile | 0.350 | —0 | — | |
| Quality %ile | 0.350 | —0 | — | |
| Momentum %ile | 0.350 | —0 | — | |
| F-Score | 2.000 | —1 | — | |
| Confidence | 0.848 | —1 | — | |
| Volatility | 0.622 | —1 | — |
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
Price / Sales
22.74
Price / Book
2.54
FCF Yield
-20.4%
Sales Yield (1/P·S)
0.0477
Shareholder Yield
Div + net buyback / mktcap
0.0%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
-56.7%
Return on Assets
-45.7%
Net Margin
-508.5%
Operating Margin
-513.7%
Gross Profit / Assets
Novy-Marx GPA
8.9%
Debt / Equity
0.24
Current Ratio
15.15
Accruals Ratio
(NI-OCF)/Assets — lower=better
-0.072
MomentumPrice trend strength over different horizons
6M Return
-50.7%
12M Return
7.5%
12-1 Momentum
Jegadeesh-Titman (skip recent month)
13.1%
Risk-Adjusted Momentum
Mom 12-1 ÷ Vol
0.21
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Earnings Stability (CV)
Lower = more stable
0.317
5yr Consistent
EPS up every year for 5 years
Yes
Piotroski F-Score
2
Dividend Yield
0.0%
Buyback Yield
0.0%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
65
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
65
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
65
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Quarterly Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity